ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Lipid-lowering Drugs Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-14J14176
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Lipid lowering Drugs Market Research Report 2023
BUY CHAPTERS

Global Lipid-lowering Drugs Market Research Report 2025

Code: QYRE-Auto-14J14176
Report
May 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
Pfizer Inc
GlaxoSmithKline PLC
Novartis
Merck& Co. Inc
Amgen Inc
Takeda Pharmaceutical Company Limited
Sun Pharmaceutical Industries Ltd.
AbbVie
VIATRIS (Mylan N.V.)
Astrazeneca plc
Dr. Reddy’s Laboratories Ltd.

Lipid-lowering Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Lipid-lowering Drugs Market

Lipid-lowering Drugs Market

The global market for Lipid-lowering Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Lipid-lowering Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lipid-lowering Drugs.
The Lipid-lowering Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lipid-lowering Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lipid-lowering Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Lipid-lowering Drugs Market Report

Report Metric Details
Report Name Lipid-lowering Drugs Market
CAGR 5%
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi, Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., AbbVie, Inc., Viatris (Mylan N.V.), AstraZeneca PLC, Dr. Reddy’s Laboratories Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Lipid-lowering Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Lipid-lowering Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Lipid-lowering Drugs Market report?

Ans: The main players in the Lipid-lowering Drugs Market are Sanofi, Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., AbbVie, Inc., Viatris (Mylan N.V.), AstraZeneca PLC, Dr. Reddy’s Laboratories Ltd.

What are the Application segmentation covered in the Lipid-lowering Drugs Market report?

Ans: The Applications covered in the Lipid-lowering Drugs Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Lipid-lowering Drugs Market report?

Ans: The Types covered in the Lipid-lowering Drugs Market report are Statins & Combination, PCSK9 Inhibitors, Bile Acid Sequestrants, Fibrates, Cholesterol Absorption Inhibitors, Others

Recommended Reports

Pharmaceutical Drugs

Cardiovascular Medications

Pharmaceutical Services & Devices

1 Lipid-lowering Drugs Market Overview
1.1 Product Definition
1.2 Lipid-lowering Drugs by Type
1.2.1 Global Lipid-lowering Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Statins & Combination
1.2.3 PCSK9 Inhibitors
1.2.4 Bile Acid Sequestrants
1.2.5 Fibrates
1.2.6 Cholesterol Absorption Inhibitors
1.2.7 Others
1.3 Lipid-lowering Drugs by Application
1.3.1 Global Lipid-lowering Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Lipid-lowering Drugs Market Size Estimates and Forecasts
1.4.1 Global Lipid-lowering Drugs Revenue 2020-2031
1.4.2 Global Lipid-lowering Drugs Sales 2020-2031
1.4.3 Global Lipid-lowering Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Lipid-lowering Drugs Market Competition by Manufacturers
2.1 Global Lipid-lowering Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Lipid-lowering Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Lipid-lowering Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Lipid-lowering Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Lipid-lowering Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Lipid-lowering Drugs, Product Type & Application
2.7 Global Key Manufacturers of Lipid-lowering Drugs, Date of Enter into This Industry
2.8 Global Lipid-lowering Drugs Market Competitive Situation and Trends
2.8.1 Global Lipid-lowering Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Lipid-lowering Drugs Players Market Share by Revenue
2.8.3 Global Lipid-lowering Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Lipid-lowering Drugs Market Scenario by Region
3.1 Global Lipid-lowering Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Lipid-lowering Drugs Sales by Region: 2020-2031
3.2.1 Global Lipid-lowering Drugs Sales by Region: 2020-2025
3.2.2 Global Lipid-lowering Drugs Sales by Region: 2026-2031
3.3 Global Lipid-lowering Drugs Revenue by Region: 2020-2031
3.3.1 Global Lipid-lowering Drugs Revenue by Region: 2020-2025
3.3.2 Global Lipid-lowering Drugs Revenue by Region: 2026-2031
3.4 North America Lipid-lowering Drugs Market Facts & Figures by Country
3.4.1 North America Lipid-lowering Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Lipid-lowering Drugs Sales by Country (2020-2031)
3.4.3 North America Lipid-lowering Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Lipid-lowering Drugs Market Facts & Figures by Country
3.5.1 Europe Lipid-lowering Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Lipid-lowering Drugs Sales by Country (2020-2031)
3.5.3 Europe Lipid-lowering Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lipid-lowering Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Lipid-lowering Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Lipid-lowering Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Lipid-lowering Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Lipid-lowering Drugs Market Facts & Figures by Country
3.7.1 Latin America Lipid-lowering Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Lipid-lowering Drugs Sales by Country (2020-2031)
3.7.3 Latin America Lipid-lowering Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Lipid-lowering Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Lipid-lowering Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Lipid-lowering Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Lipid-lowering Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lipid-lowering Drugs Sales by Type (2020-2031)
4.1.1 Global Lipid-lowering Drugs Sales by Type (2020-2025)
4.1.2 Global Lipid-lowering Drugs Sales by Type (2026-2031)
4.1.3 Global Lipid-lowering Drugs Sales Market Share by Type (2020-2031)
4.2 Global Lipid-lowering Drugs Revenue by Type (2020-2031)
4.2.1 Global Lipid-lowering Drugs Revenue by Type (2020-2025)
4.2.2 Global Lipid-lowering Drugs Revenue by Type (2026-2031)
4.2.3 Global Lipid-lowering Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Lipid-lowering Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Lipid-lowering Drugs Sales by Application (2020-2031)
5.1.1 Global Lipid-lowering Drugs Sales by Application (2020-2025)
5.1.2 Global Lipid-lowering Drugs Sales by Application (2026-2031)
5.1.3 Global Lipid-lowering Drugs Sales Market Share by Application (2020-2031)
5.2 Global Lipid-lowering Drugs Revenue by Application (2020-2031)
5.2.1 Global Lipid-lowering Drugs Revenue by Application (2020-2025)
5.2.2 Global Lipid-lowering Drugs Revenue by Application (2026-2031)
5.2.3 Global Lipid-lowering Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Lipid-lowering Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Lipid-lowering Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Lipid-lowering Drugs Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Pfizer, Inc.
6.2.1 Pfizer, Inc. Company Information
6.2.2 Pfizer, Inc. Description and Business Overview
6.2.3 Pfizer, Inc. Lipid-lowering Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer, Inc. Lipid-lowering Drugs Product Portfolio
6.2.5 Pfizer, Inc. Recent Developments/Updates
6.3 GlaxoSmithKline plc
6.3.1 GlaxoSmithKline plc Company Information
6.3.2 GlaxoSmithKline plc Description and Business Overview
6.3.3 GlaxoSmithKline plc Lipid-lowering Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GlaxoSmithKline plc Lipid-lowering Drugs Product Portfolio
6.3.5 GlaxoSmithKline plc Recent Developments/Updates
6.4 Novartis AG
6.4.1 Novartis AG Company Information
6.4.2 Novartis AG Description and Business Overview
6.4.3 Novartis AG Lipid-lowering Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novartis AG Lipid-lowering Drugs Product Portfolio
6.4.5 Novartis AG Recent Developments/Updates
6.5 Merck & Co., Inc.
6.5.1 Merck & Co., Inc. Company Information
6.5.2 Merck & Co., Inc. Description and Business Overview
6.5.3 Merck & Co., Inc. Lipid-lowering Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Merck & Co., Inc. Lipid-lowering Drugs Product Portfolio
6.5.5 Merck & Co., Inc. Recent Developments/Updates
6.6 Amgen Inc.
6.6.1 Amgen Inc. Company Information
6.6.2 Amgen Inc. Description and Business Overview
6.6.3 Amgen Inc. Lipid-lowering Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Amgen Inc. Lipid-lowering Drugs Product Portfolio
6.6.5 Amgen Inc. Recent Developments/Updates
6.7 Takeda Pharmaceutical Company Limited
6.7.1 Takeda Pharmaceutical Company Limited Company Information
6.7.2 Takeda Pharmaceutical Company Limited Description and Business Overview
6.7.3 Takeda Pharmaceutical Company Limited Lipid-lowering Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Takeda Pharmaceutical Company Limited Lipid-lowering Drugs Product Portfolio
6.7.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
6.8 Sun Pharmaceutical Industries Ltd.
6.8.1 Sun Pharmaceutical Industries Ltd. Company Information
6.8.2 Sun Pharmaceutical Industries Ltd. Description and Business Overview
6.8.3 Sun Pharmaceutical Industries Ltd. Lipid-lowering Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sun Pharmaceutical Industries Ltd. Lipid-lowering Drugs Product Portfolio
6.8.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
6.9 AbbVie, Inc.
6.9.1 AbbVie, Inc. Company Information
6.9.2 AbbVie, Inc. Description and Business Overview
6.9.3 AbbVie, Inc. Lipid-lowering Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 AbbVie, Inc. Lipid-lowering Drugs Product Portfolio
6.9.5 AbbVie, Inc. Recent Developments/Updates
6.10 Viatris (Mylan N.V.)
6.10.1 Viatris (Mylan N.V.) Company Information
6.10.2 Viatris (Mylan N.V.) Description and Business Overview
6.10.3 Viatris (Mylan N.V.) Lipid-lowering Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Viatris (Mylan N.V.) Lipid-lowering Drugs Product Portfolio
6.10.5 Viatris (Mylan N.V.) Recent Developments/Updates
6.11 AstraZeneca PLC
6.11.1 AstraZeneca PLC Company Information
6.11.2 AstraZeneca PLC Description and Business Overview
6.11.3 AstraZeneca PLC Lipid-lowering Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 AstraZeneca PLC Lipid-lowering Drugs Product Portfolio
6.11.5 AstraZeneca PLC Recent Developments/Updates
6.12 Dr. Reddy’s Laboratories Ltd.
6.12.1 Dr. Reddy’s Laboratories Ltd. Company Information
6.12.2 Dr. Reddy’s Laboratories Ltd. Description and Business Overview
6.12.3 Dr. Reddy’s Laboratories Ltd. Lipid-lowering Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Dr. Reddy’s Laboratories Ltd. Lipid-lowering Drugs Product Portfolio
6.12.5 Dr. Reddy’s Laboratories Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lipid-lowering Drugs Industry Chain Analysis
7.2 Lipid-lowering Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lipid-lowering Drugs Production Mode & Process Analysis
7.4 Lipid-lowering Drugs Sales and Marketing
7.4.1 Lipid-lowering Drugs Sales Channels
7.4.2 Lipid-lowering Drugs Distributors
7.5 Lipid-lowering Drugs Customer Analysis
8 Lipid-lowering Drugs Market Dynamics
8.1 Lipid-lowering Drugs Industry Trends
8.2 Lipid-lowering Drugs Market Drivers
8.3 Lipid-lowering Drugs Market Challenges
8.4 Lipid-lowering Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi
Pfizer Inc
GlaxoSmithKline PLC
Novartis
Merck& Co. Inc
Amgen Inc
Takeda Pharmaceutical Company Limited
Sun Pharmaceutical Industries Ltd.
AbbVie
VIATRIS (Mylan N.V.)
Astrazeneca plc
Dr. Reddy’s Laboratories Ltd.
List of Tables
 Table 1. Global Lipid-lowering Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Lipid-lowering Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Lipid-lowering Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Lipid-lowering Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Lipid-lowering Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Lipid-lowering Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Lipid-lowering Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Lipid-lowering Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Lipid-lowering Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Lipid-lowering Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Lipid-lowering Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Lipid-lowering Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Lipid-lowering Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lipid-lowering Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Lipid-lowering Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Lipid-lowering Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Lipid-lowering Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Lipid-lowering Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Lipid-lowering Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Lipid-lowering Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Lipid-lowering Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Lipid-lowering Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Lipid-lowering Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Lipid-lowering Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Lipid-lowering Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Lipid-lowering Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Lipid-lowering Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Lipid-lowering Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Lipid-lowering Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Lipid-lowering Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Lipid-lowering Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Lipid-lowering Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Lipid-lowering Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Lipid-lowering Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Lipid-lowering Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Lipid-lowering Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Lipid-lowering Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Lipid-lowering Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Lipid-lowering Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Lipid-lowering Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Lipid-lowering Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Lipid-lowering Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Lipid-lowering Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Lipid-lowering Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Lipid-lowering Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Lipid-lowering Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Lipid-lowering Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Lipid-lowering Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Lipid-lowering Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Lipid-lowering Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Lipid-lowering Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Lipid-lowering Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Lipid-lowering Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Lipid-lowering Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Lipid-lowering Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Lipid-lowering Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Lipid-lowering Drugs Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Lipid-lowering Drugs Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Lipid-lowering Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Lipid-lowering Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Lipid-lowering Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Lipid-lowering Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Lipid-lowering Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Lipid-lowering Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Lipid-lowering Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Lipid-lowering Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Lipid-lowering Drugs Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Lipid-lowering Drugs Price (US$/Unit) by Application (2026-2031)
 Table 70. Sanofi Company Information
 Table 71. Sanofi Description and Business Overview
 Table 72. Sanofi Lipid-lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Sanofi Lipid-lowering Drugs Product
 Table 74. Sanofi Recent Developments/Updates
 Table 75. Pfizer, Inc. Company Information
 Table 76. Pfizer, Inc. Description and Business Overview
 Table 77. Pfizer, Inc. Lipid-lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Pfizer, Inc. Lipid-lowering Drugs Product
 Table 79. Pfizer, Inc. Recent Developments/Updates
 Table 80. GlaxoSmithKline plc Company Information
 Table 81. GlaxoSmithKline plc Description and Business Overview
 Table 82. GlaxoSmithKline plc Lipid-lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. GlaxoSmithKline plc Lipid-lowering Drugs Product
 Table 84. GlaxoSmithKline plc Recent Developments/Updates
 Table 85. Novartis AG Company Information
 Table 86. Novartis AG Description and Business Overview
 Table 87. Novartis AG Lipid-lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Novartis AG Lipid-lowering Drugs Product
 Table 89. Novartis AG Recent Developments/Updates
 Table 90. Merck & Co., Inc. Company Information
 Table 91. Merck & Co., Inc. Description and Business Overview
 Table 92. Merck & Co., Inc. Lipid-lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Merck & Co., Inc. Lipid-lowering Drugs Product
 Table 94. Merck & Co., Inc. Recent Developments/Updates
 Table 95. Amgen Inc. Company Information
 Table 96. Amgen Inc. Description and Business Overview
 Table 97. Amgen Inc. Lipid-lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Amgen Inc. Lipid-lowering Drugs Product
 Table 99. Amgen Inc. Recent Developments/Updates
 Table 100. Takeda Pharmaceutical Company Limited Company Information
 Table 101. Takeda Pharmaceutical Company Limited Description and Business Overview
 Table 102. Takeda Pharmaceutical Company Limited Lipid-lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Takeda Pharmaceutical Company Limited Lipid-lowering Drugs Product
 Table 104. Takeda Pharmaceutical Company Limited Recent Developments/Updates
 Table 105. Sun Pharmaceutical Industries Ltd. Company Information
 Table 106. Sun Pharmaceutical Industries Ltd. Description and Business Overview
 Table 107. Sun Pharmaceutical Industries Ltd. Lipid-lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Sun Pharmaceutical Industries Ltd. Lipid-lowering Drugs Product
 Table 109. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
 Table 110. AbbVie, Inc. Company Information
 Table 111. AbbVie, Inc. Description and Business Overview
 Table 112. AbbVie, Inc. Lipid-lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. AbbVie, Inc. Lipid-lowering Drugs Product
 Table 114. AbbVie, Inc. Recent Developments/Updates
 Table 115. Viatris (Mylan N.V.) Company Information
 Table 116. Viatris (Mylan N.V.) Description and Business Overview
 Table 117. Viatris (Mylan N.V.) Lipid-lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Viatris (Mylan N.V.) Lipid-lowering Drugs Product
 Table 119. Viatris (Mylan N.V.) Recent Developments/Updates
 Table 120. AstraZeneca PLC Company Information
 Table 121. AstraZeneca PLC Description and Business Overview
 Table 122. AstraZeneca PLC Lipid-lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. AstraZeneca PLC Lipid-lowering Drugs Product
 Table 124. AstraZeneca PLC Recent Developments/Updates
 Table 125. Dr. Reddy’s Laboratories Ltd. Company Information
 Table 126. Dr. Reddy’s Laboratories Ltd. Description and Business Overview
 Table 127. Dr. Reddy’s Laboratories Ltd. Lipid-lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Dr. Reddy’s Laboratories Ltd. Lipid-lowering Drugs Product
 Table 129. Dr. Reddy’s Laboratories Ltd. Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Lipid-lowering Drugs Distributors List
 Table 133. Lipid-lowering Drugs Customers List
 Table 134. Lipid-lowering Drugs Market Trends
 Table 135. Lipid-lowering Drugs Market Drivers
 Table 136. Lipid-lowering Drugs Market Challenges
 Table 137. Lipid-lowering Drugs Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Lipid-lowering Drugs
 Figure 2. Global Lipid-lowering Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Lipid-lowering Drugs Market Share by Type: 2024 & 2031
 Figure 4. Statins & Combination Product Picture
 Figure 5. PCSK9 Inhibitors Product Picture
 Figure 6. Bile Acid Sequestrants Product Picture
 Figure 7. Fibrates Product Picture
 Figure 8. Cholesterol Absorption Inhibitors Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global Lipid-lowering Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Lipid-lowering Drugs Market Share by Application: 2024 & 2031
 Figure 12. Hospital Pharmacies
 Figure 13. Retail Pharmacies
 Figure 14. Online Pharmacies
 Figure 15. Global Lipid-lowering Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Lipid-lowering Drugs Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Lipid-lowering Drugs Sales (2020-2031) & (K Units)
 Figure 18. Global Lipid-lowering Drugs Average Price (US$/Unit) & (2020-2031)
 Figure 19. Lipid-lowering Drugs Report Years Considered
 Figure 20. Lipid-lowering Drugs Sales Share by Manufacturers in 2024
 Figure 21. Global Lipid-lowering Drugs Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Lipid-lowering Drugs Players: Market Share by Revenue in Lipid-lowering Drugs in 2024
 Figure 23. Lipid-lowering Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Lipid-lowering Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Lipid-lowering Drugs Sales Market Share by Country (2020-2031)
 Figure 26. North America Lipid-lowering Drugs Revenue Market Share by Country (2020-2031)
 Figure 27. United States Lipid-lowering Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Lipid-lowering Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Lipid-lowering Drugs Sales Market Share by Country (2020-2031)
 Figure 30. Europe Lipid-lowering Drugs Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Lipid-lowering Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Lipid-lowering Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Lipid-lowering Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Lipid-lowering Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Lipid-lowering Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Lipid-lowering Drugs Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Lipid-lowering Drugs Revenue Market Share by Region (2020-2031)
 Figure 38. China Lipid-lowering Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Lipid-lowering Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Lipid-lowering Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Lipid-lowering Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Lipid-lowering Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. China Taiwan Lipid-lowering Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Southeast Asia Lipid-lowering Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Lipid-lowering Drugs Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Lipid-lowering Drugs Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Lipid-lowering Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Lipid-lowering Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Lipid-lowering Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Lipid-lowering Drugs Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Lipid-lowering Drugs Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Lipid-lowering Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Lipid-lowering Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Lipid-lowering Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Lipid-lowering Drugs by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Lipid-lowering Drugs by Type (2020-2031)
 Figure 57. Global Lipid-lowering Drugs Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Lipid-lowering Drugs by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Lipid-lowering Drugs by Application (2020-2031)
 Figure 60. Global Lipid-lowering Drugs Price (US$/Unit) by Application (2020-2031)
 Figure 61. Lipid-lowering Drugs Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Cholesterol Lowering Drugs Market Research Report 2024
Cholesterol Reducer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hyperlipidemia Prescription Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hyperlipidemia Drugs Market Research Report 2024
Lipids Active Pharmaceutical Ingredient Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmaceutical Grade Cholesterol Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drugs to Treat Hypertriglyceridemia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cardiovascular Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Still s Disease Treatment Market Research Report 2025
Anti Hypertensive Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Weight loss Drugs Market Insights Forecast to 2030
Antidepressants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmaceutical Grade Phospholipids Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Weight Reduction Medicine Market Research Report 2024
Global Hypertriglyceridemia Treatment Market Research Report 2025
Chronic Metabolic Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cardiac Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Depression MDD Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions